These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7061844)

  • 1. Hemolytic efficiency of cell-bound IgM: evidence that IgM-C1 complexes activate C4 molecules not hemolytic with homologous C2--C9.
    Ejzemberg R; Borsos T
    J Immunol; 1982 Apr; 128(4):1600-2. PubMed ID: 7061844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.
    Füst G; Medgyesi GA; Rajnavölgyi E; Csécsi-Nagy M; Czikora K; Gergely J
    Immunology; 1978 Dec; 35(6):873-84. PubMed ID: 104923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing effect of concanavalin A on the hemolytic activity of anti-Forssman IgG: the role of C1.
    Langone JJ; Sandor M; Ejzemberg R
    J Immunol; 1982 Sep; 129(3):1159-64. PubMed ID: 7108204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement fixation by rheumatoid factor.
    Tanimoto K; Cooper NR; Johnson JS; Vaughan JH
    J Clin Invest; 1975 Mar; 55(3):437-45. PubMed ID: 1078825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
    Houle JJ; Hoffmann EM
    J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement-mediated hemolytic activity of succinylated concanavalin A: preparation and activity of cell intermediates.
    Langone JJ; Ejzemberg R
    J Immunol; 1985 Feb; 134(2):1110-4. PubMed ID: 3965569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.
    Beebe DP; Cooper NR
    J Immunol; 1981 Apr; 126(4):1562-8. PubMed ID: 6259260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement.
    Betz SJ; Page N; Estrade C; Isliker H
    J Immunol; 1982 Feb; 128(2):707-11. PubMed ID: 7033382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C4 does not bind to human and rabbit IgM during activation of the classical complement pathway on the red cell.
    Circolo A; Borsos T
    J Immunol; 1982 Oct; 129(4):1485-8. PubMed ID: 7108214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding and activation of hemolytic complement by IgG antibodies: cooperativity between antibodies of different hapten specificity.
    Borsos T; Circolo A
    J Immunol; 1985 Jan; 134(1):492-4. PubMed ID: 3964818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing of hemolytic complement components in domestic animals.
    Barta O; Hubbert NL
    Am J Vet Res; 1978 Aug; 39(8):1303-8. PubMed ID: 697137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte-derived complement inhibitor. IV. The functional properties of C1 bound to erythrocytes pretreated with leukocyte culture supernatant.
    Bernard A; Walter W; Teshima H; Boumsell L; Good RA; Day NK
    J Immunol; 1976 Oct; 117(4):1117-26. PubMed ID: 977945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of immune precipitation by purified classical pathway complement components.
    Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
    Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of lymphocyte proliferative responses to mitogens and antigens by complement components C1, C4 and C2.
    Laham MN; Caldwell JR; Panush RS
    J Clin Lab Immunol; 1982 Oct; 9(1):39-47. PubMed ID: 6983586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease.
    Böttger EC; Hoffmann T; Hadding U; Bitter-Suermann D
    J Clin Invest; 1986 Sep; 78(3):689-95. PubMed ID: 2427541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the interaction between protein A and immunoglobulin G. I. Effect of protein A on the functional activity of IgG.
    Langone JJ; Boyle MD; Borsos T
    J Immunol; 1978 Jul; 121(1):327-32. PubMed ID: 353195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement-dependent cytotoxic antitumor antibody. II. Quantitative determination of cell-bound immunoglobulin M1.
    Boyle MD; Langone JJ
    J Natl Cancer Inst; 1979 Jun; 62(6):1537-44. PubMed ID: 286124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysis of tumor cells by antibody and complement. II. Lack of correlation between amount of C4 and C3 fixed and cell lysis.
    Ohanian SH; Borsos T
    J Immunol; 1975 Apr; 114(4):1292-5. PubMed ID: 163862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.